Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 131. Tumors of the Digestive System
Topics: Introduction | Noncancerous Tumors of the Esophagus | Cancer of the Esophagus | Noncancerous Tumors of the Stomach | Cancer of the Stomach | Noncancerous Tumors of the Small Intestine | Cancer of the Small Intestine | Polyps of the Large Intestine and Rectum | Colorectal Cancer | Cancer of the Anus | Cancer of the Pancreas | Other Tumors of the Pancreas
 
green line

Cancer of the Stomach

About 95% of stomach cancers are adenocarcinomas. Adenocarcinomas of the stomach originate from the glandular cells of the stomach lining.

In the United States, adenocarcinoma of the stomach occurs in about 8 of 100,000 people each year and is the seventh most common cause of cancer death. It is more common among certain populations: people aged 50 and older, poor people, blacks, and people who live in northern climates. For unknown reasons, adenocarcinoma of the stomach is becoming less common in the United States. It is far more common in Japan, China, Chile, and Iceland; in these nations, screening programs are an important means of early detection.

Causes and Risk Factors

The cause of adenocarcinoma of the stomach is unknown. It often begins at a site where the stomach lining is inflamed. However, many experts now believe that inflammation is the result of adenocarcinoma rather than the cause of it. Certain foods, especially smoked foods, are suspected as contributing to stomach cancer.

Some experts suggest that peptic ulcers in the stomach can lead to adenocarcinoma, but most people with ulcers and adenocarcinoma probably had an undetected cancer before the ulcers developed. The bacterium Helicobacter pylori, which plays a role in producing ulcers, likely plays a role in the development of adenocarcinoma.

Stomach polyps may become cancerous and are thus removed. Adenocarcinoma of the stomach is particularly likely to develop if the polyps consist of glandular cells, if the polyps are larger than ¾ inch, or if several polyps exist.

Certain dietary factors were once thought to play a role in the development of adenocarcinoma of the stomach. These factors included a high intake of salt, a high intake of carbohydrates, a high intake of preservatives called nitrates (often present in smoked foods), and a low intake of fruit and green leafy vegetables. However, none of these factors has been proven to be a cause.

click here to view the sidebar See the sidebar Rare Types of Stomach Cancer.

Symptoms

In the early stages, symptoms are vague and easily ignored. Early symptoms may mimic peptic ulcer disease, with burning abdominal pain. Therefore, peptic ulcer symptoms that do not resolve with treatment may indicate stomach cancer. The person may notice a feeling of fullness after a small meal (early satiety).

Weight loss or weakness usually results from difficulty in eating or from an inability to absorb some vitamins and minerals. Anemia, characterized by fatigue, weakness, and light-headedness, may result from very gradual bleeding that causes no other symptoms, from malabsorption of vitamin B12 (a vitamin needed for red blood cell formation), or from malabsorption of iron (a mineral needed for red blood cell formation) due to a lack of stomach acid. Uncommonly, a person may vomit large amounts of blood (hematemesis) or pass black tarry stools (melena). When adenocarcinoma is advanced, a doctor may be able to feel a mass when pressing on the abdomen.

Even in the early stages, a small adenocarcinoma may spread (metastasize) to distant sites. The spread of the tumor may cause liver enlargement, jaundice (a yellowish discoloration of the skin and the whites of the eyes), ascites (fluid accumulation and swelling in the abdominal cavity), and cancerous skin nodules. The spreading cancer also may weaken bones, leading to bone fractures.

Diagnosis

Endoscopy (an examination in which a flexible tube is used to visualize the inside of the digestive tract) is the best diagnostic procedure. It allows a doctor to view the stomach directly, to check for Helicobacter pylori, and to remove tissue samples for examination under a microscope (biopsy). Barium x-rays are used less often because they rarely reveal small early-stage cancers and do not allow for biopsy.

Prognosis and Treatment

Fewer than 20% of people with adenocarcinoma of the stomach survive longer than 5 years. The cancer tends to spread early to other sites. If the cancer is confined to the stomach, surgery is usually performed to try to cure it. Removal of the entire tumor before it has spread offers the only hope of cure. Most or all of the stomach and nearby lymph nodes are removed. The prognosis is good if the cancer has not penetrated the stomach wall too deeply. In the United States, the results of surgery are often poor, because most people have extensive cancer by the time a diagnosis is made. In Japan, where stomach cancer is very common, mass public health screening programs help to detect it early so that a cure is more likely. Chemotherapy and radiation therapy do not usually improve survival time after surgery.

If the cancer has spread beyond the stomach, surgery cannot cure the condition, but it is sometimes used to relieve symptoms. For example, if the passage of food is obstructed at the far end of the stomach, a bypass operation, in which an alternate connection is made between the stomach and the small intestine, allows food to pass. This connection relieves the symptoms of obstruction--pain and vomiting--at least for a while. Chemotherapy and radiation therapy may relieve symptoms as well, but their effectiveness is limited.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.